Previous post Next post

Swiss Research Leads to Cancer Break Through

Researchers at the Paul Scherrer Institute recently deciphered the structure of the CC chemokine receptor 7 (CCR7), a signaling protein.

© Bogdan Hoda | Dreamstime.com

Cancer cells use CCR7 to guide themselves into the lymphatic system, spreading cancer throughout the body. The resulting secondary tumors, called metastases, are responsible for most cancer deaths.

This new understanding of CCR7 is a break through that forms a foundation for developing drugs that could lead to treatments to reduce the spread of certain types of cancer, including colorectal cancer, the second most common malignant tumor worldwide.

Based on this work, scientists at the Swiss pharmaceutical giant Roche found a number of compounds in their database that might block the CCR7 signaling protein and be used to develop a new drug to reduce the spread of cancer.

The Paul Scherrer Institute is Switzerland’s largest research institute, with 2,100 staff and an annual budget of around CHF407 million, according to the Institute’s website.

More on this:
Discovery article published in Cell (in English)

Full story here Are you the author?
About Investec
Investec
Investec is a distinctive Specialist Bank and Asset Manager. We provide a diverse range of financial products and services to a niche client base in three principal markets, the United Kingdom, South Africa and Australia, as well as certain other geographies. Investec’s strategic goals are motivated by the desire to develop an efficient and integrated business on an international scale through the active pursuit of clearly established core competencies in the group’s principal business areas.
Previous post See more for 3.) Investec Next post
Tags:

Permanent link to this article: https://snbchf.com/2019/08/investec-swiss-research-leads-cancer/

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

This site uses Akismet to reduce spam. Learn how your comment data is processed.